All Bulletins

Seed Planning Survey: Japan’s Self-Pay Stem Cell & PRP Market to Reach JPY 27.9 Billion by 2030 Posted on: October 2, 2026 Author: 株式会社シード・プランニング

[UTokyo at BioJapan 2026] UTokyo Exhibition: 15 Rising Startups & Young Researchers to Present! Posted on: September 29, 2026 Author: 東京大学

GHIT Fund Launches “NTDpedia” to Help Turn Apathy into Action Against Neglected Tropical Diseases Posted on: September 17, 2026 Author: Global Health Innovative Technology Fund (GHIT Fund)

C4U and Cellafa Bioscience Enter Into A Collaborative Research Agreement Posted on: August 24, 2026 Author: Ｃ４Ｕ株式会社

IDT will be paticipating at NAIS 2026 (International Society of Nucleic Acid Immunity Annual Meeting) Posted on: August 10, 2026 Author: Integrated DNA Technologies(株)

C4U and Jichi Medical University Enter Into an Agreement on Co-Ownership of a Patent Right Posted on: July 27, 2026 Author: Ｃ４Ｕ株式会社

GHIT Fund Invests Approx. JPY 140 Million in a Portable Rapid Diagnostic System for Ebola Disease in a Joint Project Between Osaka Metropolitan University, K.K. DNAFORM, and INRB Posted on: July 23, 2026 Author: Global Health Innovative Technology Fund (GHIT Fund)

Japan convenes global leaders in malaria research and development to strengthen partnerships for innovative prevention and treatment tools Posted on: July 22, 2026 Author: Global Health Innovative Technology Fund (GHIT Fund)

[7/27 Hybrid](India) Medical Excellence India Research Debriefing: Registration open! Posted on: July 17, 2026 Author: 一般社団法人Medical Excellence JAPAN

Total Investment of Approx. USD 18 Million in Malaria, Tuberculosis and NTD R&D Projects with Partners Including Shionogi, Eisai, Nagasaki, Ehime and Niigata University Posted on: July 13, 2026 Author: 公益社団法人グローバルヘルス技術振興基金

A Divisional Patent of CRISPR-Cas3 Basic Patent Issued in Japan (Patent No. 7886063) Posted on: July 8, 2026 Author: Ｃ４Ｕ株式会社

【Call for Participants!】Financial Strategies for Early-Stage Biotech Companies Posted on: June 22, 2026 Author: 川崎市産業振興財団